Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...

China NMPA clears Mabwell’s IND for B7-H3 ADC in combination with PD-1/VEGF bispecific antibody for patients with advanced solid tumours: Shanghai Friday, January 2, 2026, 12:00 ...

Advances in technology transforming the approach to prostate cancer: Dr Likhiteswer Pallagani: Shardul Nautiyal, Mumbai Friday, January 2, 2026, 10:00 Hrs [IST] The advances in te ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 09:00 Hrs [IST] ...

Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 08:00 Hrs [IST] ...

BDCDA calls on retailers & wholesalers to uphold ethical trade, steer clear of illegal practices: Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 08:00 Hrs [IST] The Banga ...

DoP includes member of HTAIn in expert committee on pricing of drugs: Gireesh Babu, New Delhi Friday, January 2, 2026, 08:00 Hrs [IST] Department of Pharmaceuticals (DoP) has adde ...

Proposed VBSA Bill to mandate radical transparency for pharmacy education: Peethaambaran Kunnathoor, Chennai Friday, January 2, 2026, 08:00 Hrs [IST] The proposed Viksit Bharat Sh ...

SOFIE Biosciences doses first patient dosed in phase 3 trials of [18F]FAPI-74, a fluorine-18 labelled radiopharmaceutical targeting FAP for patients with GI cancers: Dulles, Virgi ...

Ultragenyx Pharma announces phase 3 Orbit & Cosmic results for setrusumab in osteogenesis imperfecta: Novato, California Wednesday, December 31, 2025, 18:00 Hrs [IST] Ultragenyx P ...

China NMPA accepts and grants priority review status to Hutchmed’s NDA for fanregratinib in second-line intrahepatic cholangiocarcinoma: Hong Kong, Shanghai Wednesday, December ...